Academic research brings people close together as they collaborate on shared goals and projects that often last decades. Saying goodbye to a collaborator can be as hard as saying goodbye to family.
Pediatric cancer is one of the cruelest of diseases, and caregivers develop special skills to help their patients. Research shows that caregivers for adults could learn some things from them.
A cancer is in remission when it can no longer be detected. But we only say it's cured when it hasn't come back for a certain time – and that differs for different cancers.
Immunotherapy drugs work by increasing the patient's own immune response. The most successful examples of immunotherapies are drugs that act as antibodies, of which Keytruda is one.
Great strides have been made in cancer medicine over decades, but it's important not to forget the growing role that kindness and empathy play in good care.
Some argue the current system of subsidising drugs in Australia needs changing to accommodate new cancer therapies. But two recent drug listings show the current system is working perfectly well.
Why hasn't there been an improvement in survival in the last 30 years for patients with brain cancers?
Leukaemia used to be a death sentence. Now, the survival rate for the most common form in children is 85%. We can apply similar strategies to how we approach childhood brain cancer.
Researchers have long been looking for clues into how to treat triple negative breast cancer. Could fighter blood cells that infiltrate the tumor provide insight?
Poor people who have cancer are one of the most financially vulnerable groups in the US. Obamacare aimed to improve their access to care. A recent study shows how it did.
Men diagnosed with prostate cancer should be given all their options for treatment before they make a decision. In Australia today, this isn't the rule, but the exception.
The high cost of cancer drugs in South Africa has come under the spotlight with an investigation by the Competition Commission in the country.
Successful policy interventions, especially those in the social realm influenced by the vagaries of human behaviour, don’t seem to travel well.
Nanoparticles are a form of transport for drugs and can go places drugs wouldn't be able to go on their own. They make drug delivery more targeted, reducing collateral damage to healthy tissues.
The composition of bacteria in our gut regulates our immune system. Modifying it - through poo transplants for example - can control cancer risk, as well as response to treatment.
Getting the right amount of radiation is a fine balance between therapy and harm. A common way to improve the benefit-to-cure ratio is to fire multiple beams at the tumour from different directions.
Rare diseases may only affect a handful of people but their treatment benefits everyone.
It's early days, but hope is on the horizon when it comes to one of the deadliest cancers.
In Australia, there is no system in place to support people returning to work after cancer treatment – or to provide advice to their employers on how to help them.
Research in animals and humans shows periods of fasting before and after chemotherapy protects healthy cells while killing cancerous ones more efficiently.